Theranos Settlement Payment Update 2026: Second Check Status

View Open Settlements
Consumer · Health · Refund

Theranos Walgreens Settlement Payment Update: Checks Sent, Second Distribution Status

By Steve Levine

Walgreens storefront associated with the Theranos blood testing class action settlement

Published: June 15, 2026

Status Settlement Closed Final approval February 6, 2024 · checks mailed beginning April 5, 2024 · no claim form was required
Settlement Fund $44 Million Walgreens Fund ~$1.33M from remaining Theranos assets added · combined settlement resources ~$45.33 million
Estimated Payout ~$113.33 average (general class) $10 base + ~2× testing cost, less any Arizona AG refund, pro rata adjusted · Walgreens Edison Subclass flat payment est. ~$700–$1,000 additional · estimates, amounts varied
Proof Required No Payments were automatic from Theranos and Walgreens records — no claim form needed

June 2026 Update: The Theranos and Walgreens settlement remains closed, and there is no new claim form available. Initial checks began mailing automatically to eligible class members on April 5, 2024. The court-approved allocation plan permits money associated with checks remaining uncashed one year after the initial distribution to be included in a second distribution if practicable. As of June 15, 2026, the settlement administrator has not publicly confirmed that another distribution was issued. For an ongoing status check, see our Theranos settlement second distribution payment update.

What Is This Settlement About?

Theranos, Inc. once marketed itself as a breakthrough that could run a wide menu of laboratory tests from a few drops of blood drawn from a finger stick. The company partnered with Walgreens to offer testing inside select Walgreens stores. After reporting revealed the technology did not work as advertised, consumers sued, alleging the blood testing services were misleadingly marketed and that some test results were unreliable.

Walgreens is a frequent defendant in consumer class actions; separately from this Theranos matter, it resolved a prescription-pricing case — see our coverage of the $100 million Walgreens prescription pricing settlement. That case is unrelated to the Theranos litigation and is mentioned here only as another Walgreens consumer settlement.

To resolve the consumer claims, Walgreens established a non-reversionary $44 million settlement fund. In addition, approximately $1,331,094.88 from the Theranos assignment-for-the-benefit-of-creditors arrangement was added to the class recovery. That additional amount did not come from a personal payment by former Theranos president Ramesh "Sunny" Balwani; rather, Balwani agreed to withdraw his claims against the remaining Theranos assets, which allowed part of those assets to be distributed to the class. Elizabeth Holmes was not a party to these settlements. Together, these resources brought the combined settlement resources to approximately $45.33 million. Walgreens and the other defendants denied any wrongdoing and agreed to the settlement to avoid the cost and risk of continued litigation. A federal court in Arizona granted the settlement final approval on February 6, 2024.

Because this settlement is now closed and payments have already been distributed, there is no claim form to file. The information below is provided as a reference record of how the settlement worked. If you are looking for settlements you can still file for, see our open class action settlements page.

Who Qualified?

The settlement covered consumers who paid for Theranos blood testing services. The main classes were defined by where the tests were purchased and when, with a separate subclass for certain Walgreens blood draws:

Eligibility for the general class did not depend on how the test was paid for — class members qualified whether they paid out of pocket, through health insurance, or through any other source. Importantly, simply having received a finger-prick test did not, by itself, make a person a Walgreens Edison Subclass member; the finger prick had to have been performed by a Walgreens employee rather than only by a Theranos employee. According to the final approval filings, the settlement covered 198,982 class members, including 7,866 members of the Walgreens Edison Subclass.

How Much Did Class Members Get?

General class payments were calculated from a formula rather than a flat amount. Each general class member's payment started with a $10 base payment, plus approximately two times that member's Theranos testing costs. From that figure, the administrator subtracted any refund the class member had already received through the 2017 Arizona Attorney General Consent Decree with Theranos, and the result was then subject to a pro rata adjustment based on the net settlement fund. Walgreens Edison Subclass members received a separate additional payment for their battery and medical-battery claims.

The Walgreens Edison Subclass Member Payment was a flat amount per subclass member, which the settlement estimated at approximately $700 to $1,000. Final approval filings also estimated an average general class payment of approximately $113.33. These figures are administrator estimates prepared before final distribution, not guaranteed or universal payment amounts — individual general class payments varied according to each person's testing costs and any prior Arizona Attorney General refund. The fund was non-reversionary, meaning no unused money returned to Walgreens.

Court-Approved Deductions

Settlement payments were made from the net fund that remained after the court approved certain deductions. The court approved $13.2 million in attorneys' fees, $1,160,911.20 in litigation expenses, and service awards of $10,000 for each of the seven class representatives. After those amounts, along with settlement administration costs and other authorized deductions, the remaining net fund was used to pay class members.

Is There a Second Theranos Settlement Payment?

Initial settlement checks began mailing on April 5, 2024. The court-approved Plan of Allocation addresses what happens to money associated with checks that remain uncashed one year after that initial distribution. Under that plan, the residual money may be distributed again — a Theranos second distribution — to class members who cashed their initial checks, if doing so is practical. Alternatively, any remaining money may be treated as unclaimed funds under applicable state unclaimed-property procedures.

In other words, the allocation plan allows for the possibility of a second Theranos settlement check from leftover funds, but it does not guarantee one. As of June 15, 2026, the settlement administrator has not publicly announced that a second payment round was issued. Class members who want to confirm the current status should check the official settlement website, and we track developments on our Theranos settlement second distribution update.

Did You Have to File a Claim?

No. Payments were automatic for the class members the settlement administrator could identify from Theranos and Walgreens records. Eligible consumers did not have to submit a claim form, upload receipts, provide proof, or enter any administrator-issued ID to receive a payment, and there was no late-claim process because there was no claim form. Settlement checks began mailing on April 5, 2024.

For any questions about a payment, the official settlement website remains the authoritative source of information. OpenClassActions.com does not administer payments, replace checks, or possess individual class-member payment records.

Frequently Asked Questions

Is the Theranos settlement still open?

No. The settlement is closed, no claim form is available, and initial checks were mailed beginning April 5, 2024. The court granted final approval on February 6, 2024.

When were Theranos settlement checks mailed?

Initial Theranos settlement checks began mailing automatically to eligible class members on April 5, 2024. No claim form was required — the settlement administrator calculated payments from Theranos and Walgreens records.

Will there be a second Theranos settlement check?

The court-approved allocation plan permits a second distribution of funds from checks that remain uncashed one year after the initial distribution, if doing so is practical, with any remaining amounts treated as unclaimed funds under applicable state procedures. As of June 15, 2026, the settlement administrator has not publicly confirmed that a second Theranos settlement check was issued.

What happened to uncashed Theranos settlement checks?

Under the Plan of Allocation, money from checks that remain uncashed one year after the initial distribution may be included in a second distribution to class members who cashed their initial checks, if practicable, or treated as unclaimed funds under applicable state unclaimed-property procedures.

What should I do if my Theranos settlement check expired?

Contact the settlement administrator, JND Legal Administration, through the contact options on the official settlement website, TheranosLawsuit.com. We cannot promise that an expired check can still be replaced; only the administrator can address an individual check. OpenClassActions.com does not administer payments or replace checks.

Who qualified for the Walgreens Edison Subclass?

Class members whose qualifying finger-prick blood draw was performed by a Walgreens employee between November 2013 and March 2015. A finger-prick test performed only by a Theranos employee did not, by itself, make a person a subclass member.

How were payments calculated?

General class payments started with a $10 base payment plus approximately two times the class member's Theranos testing costs, minus any refund the member had already received through the 2017 Arizona Attorney General Consent Decree with Theranos, and were then subject to a pro rata adjustment based on the net settlement fund. Walgreens Edison Subclass members received a separate flat additional payment for their battery and medical-battery claims, estimated at approximately $700 to $1,000. Final approval filings also estimated an average general class payment of about $113.33.

Was Elizabeth Holmes part of the Theranos class action settlement?

No. Elizabeth Holmes was not a party to these settlements. The consumer resolution involved Walgreens, Ramesh "Sunny" Balwani, Theranos, and the entity administering Theranos' remaining assets. The official settlement website explains that claims involving Holmes were handled separately from these settlements.

How do I contact the Theranos settlement administrator?

The settlement is administered by JND Legal Administration. Use the contact options on the official settlement website, TheranosLawsuit.com, for questions about a payment or an uncashed check. OpenClassActions.com does not administer payments or hold individual class-member payment records.

Is TheranosLawsuit.com the official settlement website?

Yes. TheranosLawsuit.com is the official settlement website for In re Arizona Theranos, Inc., Litigation, administered by JND Legal Administration. It hosts the official notice, FAQ, court documents, and payment-information tools.


Other Walgreens and Medical Testing Settlements

If you are researching related cases, these other OpenClassActions.com pages may be useful:


Settlement Administrator

The settlement is administered by JND Legal Administration. Class members with questions about a payment or an uncashed check should use the contact options on the official settlement website rather than contacting OpenClassActions.com. The official website also hosts the settlement's court documents and detailed FAQ.

OpenClassActions.com does not administer payments, replace checks, or possess individual class-member payment records.

Sources


For more class actions keep scrolling below.
Settlement Amount $44M Walgreens fund (~$45.33M combined)
Case Title In re Arizona Theranos, Inc., Litigation
Case Number 2:16-cv-2138-DGC
Court U.S. District Court, District of Arizona
Final Approval February 6, 2024
Official Website Theranos Lawsuit.com